
How to Build Trust in a New Category
Interview with Wizard Wellness CEO Lorne Lucree
Sponsored by

Inside this Interviewโฆ
How Wizard educates customers about the nasal microbiome by borrowing analogies from familiar categories like skincare and gut health, and using post-purchase emails to guide customers through what to expect over time.
Why designing out friction, from fast-dissolving oral strips to premixed nasal rinses, is just as critical as technical formulation for daily adoption.
Why bringing large retailers like Walmart and Target โinto the kitchenโ before launch fosters the best feedback and accelerates the path to shelf.
What Lorne learned leading 85 chemists, technicians, and quality staff at Voyant Beauty โ and why finding the right language and connecting scientists to the bigger goal lead to optimal alignment.
About the Guest
Lorne Lucree is the founder and CEO of Wizard Wellness, a microbiome-first allergy care brand. For the past 20-plus years, he has worked in advertising at Procter & Gamble, global marketing at LโOrรฉal, product development at Estรฉe Lauder, and as an innovation advisor to Unilever Prestige. At Luxury Brand Partners, he helped launch R+Co, IGK, and ONE/SIZE by Patrick Starrr. He also served as Chief Innovation and R&D Officer at Voyant Beauty and is an Ulta Beauty accelerator mentor.
Sponsor
โโโ

The AI-native operating system for founders raising venture rounds
Metal is used by thousands of founders across 40+ countries and is backed by Y Combinator and a16z speedrun. In FY 2026 alone, founders using Metal closed 100+ rounds and raised $542M in total.
If youโre heading toward your next round, Metal helps you:
Find the right investors. See deep intelligence on the investors most likely to back your company and round.
Get warm intros. Metal maps the people in your network who can introduce you to strong-fit investors.
Get your round materials in order. Organise your deck, round memo and financial model in one place, and share them with investors through secure links.
Keep existing investors close. Build investor updates with AI so your current backers stay engaged before you go out.
Interview Summary
โItโs just like a probiotic for your nose,โ Lorne says of Wizard Wellness. When the microbiome in the gut or skin is out of balance, the barrier weakens, and the same is true in the nose, where an imbalanced microbiome is linked to allergic rhinitis. Wizard uses pre-, pro-, and postbiotics, delivered through the nose and gut, to rebalance it.
The idea took shape after Lorne landed in Spain without his usual Afrin, and a pharmacist steered him to a nasal spray made with skincare ingredients like hyaluronic acid and botanicals. It worked, and it got him curious. Store aisles for mood, gut, and sleep are filled with new non-prescription brands, while allergy care has remained largely untouched. As he puts it, there was no โArmra or Grรผns of allergy.โ
Almost one in three consumers has allergies, and Wizardโs 600-person pre-launch survey found most sufferers use three to five products. The aisle they shop in splits in two: OTC drugs come with side effects like drowsiness and rebound congestion, while natural and homeopathic options have little science behind them. Wizard sits in between, with nasal rinses, nasal sprays, inhaler sticks, and oral strips organized into three steps. In a 41-person IRB study, the Wizard routine rebalanced nasal microbiome and improved quality of life, with the biggest gains among people with the worst symptoms.
Wizard launched direct-to-consumer in January 2026 and added Amazon, TikTok Shop, and walmart.com within a few months. It has since expanded into roughly 4,000 stores, including 1,700 Walmart, 1,400 CVS, and 1,000 Target locations. The company has raised close to $7 million to date from beauty and health investors, including TrueBeauty Ventures and Able Partners.
Top Takeaways
Explain New Science Using What Consumers Already Trust
When Lorne pitched Wizard to investors, the first question he usually got was whether the nasal microbiome was real. He believes a brand that explains the science simply will usually win the day.
So he borrowed from categories where consumers were already bought in. He built the formulas around ingredients people already knew from skincare and gut health. For example, there is already a familiarity with resveratrol from Caudalie skincare and red wine, and most consumers link it to antioxidants. They know the microbiome from brands like Poppi. Lorne pitched Wizard the same way, as doing for the nose what probiotics do for the gut, which made for an easier conversation than teaching from scratch. In early concept testing, people loved the idea of probiotics in a nasal spray even though they didnโt necessarily understand what probiotics actually do.
He also teaches science in stages, a process he calls โnarrative compression.โ At the shelf, the message is simple: itโs a steroid-and-drug-free alternative that works and gives instant relief. The point about strengthening the nasal microbiome comes later, once someone is using the products.
As Wizardโs pre-launch survey showed, most allergy sufferers use three to five products. Allergy brands leave users to work out a routine by themselves, so, like a skincare line, Wizard walks people through three steps: cleanse, relieve, and balance, which Lorne saw as an easy win.
Every product also goes through consumer panel testing, and the results are emphasized on the labeling as simple percentages. Lorne says consumers trust those numbers more than abstract clinical data, much like ratings and reviews, because they want to know how it works for people like them.
โโโ
Lead with simple benefits and save the deeper science for later. Tie an unfamiliar mechanism to ingredients, products, or routines people already understand, so thereโs less to teach up front. Start with what your end users care about first, like whether it works and how fast, and educate them on the rest later.
Remove the Friction That Slows Adoption
Most people treat allergies reactively because the products are unpleasant to use. โAll allergy care sucks,โ Lorne says, so people put off buying them for as long as they can. His goal was a product people actually like to use even before symptoms start, so the team had to โdesign our way into something that people would want to adopt,โ which meant removing friction at every step of the routine.
Lorne used consumer insights to design around common complaints, like products that burn or canโt be used for more than a few days. For example, some people gag on pills, so the oral supplement is a fast-dissolving strip. Nasal rinses that need distilled water are annoying enough that people donโt want to use them, so Wizardโs come premixed. He also paid attention to taste, and to packaging people wouldnโt be embarrassed to carry in their bag.
He sees the user experience as part of what makes a product work. โDesign is just as important as the tech and the science. And I think a lot of people donโt think about the balance of the two,โ he says.
People also have to stick with it long enough to see results. Lorne says Americans are used to a โTylenol effect,โ where a pill works within 30 minutes, while most of Wizardโs benefits build over a few weeks. To keep people going, Wizardโs website lays out what users should expect by day 3, 7, and 14, and emails after purchase check in at each point to remind people what they should be feeling.
โโโ
Find and fix every small hassle in using your product. People quietly skip treatments that are unpleasant or take extra effort. When you need someone to use a product consistently, give ease of use as much attention as the science. Set expectations upfront and follow up to sustain adoption.
Bring In the People Who Know Your Customer Sooner Than You Think
Lorne spent most of his career building brands with Sephora and Ulta, where he learned that the earlier you get a retailer โin the kitchen,โ the better. Heโs clear that they shouldnโt define the brand, but they know their customers better than anybody. He says the knowledge sharing can be huge if they can tell youโre open to their feedback.
With Wizard, he admits he isnโt precious about the brand and felt real urgency to grow it quickly. He went to retailers as early as he could, even at the exploratory stage. When Walmart gave him a green light, he flew to Bentonville. He also pushed brokers to get Targetโs feedback before anything had been signed. Part of the reason was wanting to be first to market. Lorne expects bigger players to enter the category, and he wants to โown that place in the aisle.โ
Bringing retailers in early meant Wizard got feedback on things like packaging and the science, and it gave the retailers time to get to know the brand. They were excited that it stood on its own and was built on validated science. As a result, the retail conversations were some of the easiest, and the relationships have stayed collaborative. Retailers see the allergy aisle as early in its disruption, so โitโs not about you have to meet X velocity today or youโre out tomorrow,โ Lorne says. โItโs, letโs grow together.โ
โโโ
Treat early buyer feedback as real input, and show youโre open to it. Retailers and strategic partners who know your end user can tell you things you wonโt learn elsewhere. Bring them in before you commercialize and be receptive to what they say. Later conversations about deeper collaboration tend to go more smoothly when theyโve seen the product early.
How to Lead Technical Experts Outside Your Training
At Voyant Beauty, Lorne spent five years leading a team of 85 chemists, technicians, and quality staff, most of whom didnโt share his educational background. There, he learned how to walk into a room where you need credibility to get buy-in, โeven if you might not have checked all the boxes.โ Heโs upfront that he isnโt an ENT or an allergist. What he does have is curiosity and the background to build products, judge when the science is real, and get it to market.
He also learned to surround himself with the right partners to get the scientific pieces he needed. For Wizard, that meant microbiome research partners who could validate the science.
With the scientists themselves, a lot of it comes down to listening. Lorne says chemists often speak a different language, so he works to find what lands with them, sometimes by translating emotions into numbers. He also brings them into the big picture and gets them excited about the brand. Chemists are often the last to know, he says, and get less attention than creative and branding. In his view, though, formulation is what gives a brand its longevity and sets it apart. To Lorne, โthe chemists are the magic makers.โ
โโโ
Align with your technical team on the bigger goals.Theyโre often the last to hear the plan, even when their work is what sets the product apart. Leading scientists outside your training also means listening and finding the language that resonates with them.
You May Also Like
โโโ
Interview with Tivic Health CEO Jennifer Ernst: Why direct-to-consumer business models will be the next big focus in medtech, and how patients can play a key role in boosting support and evidence for over-the-counter medical devices.
Interview with Wyndly CEO Aakash Shah: Insights on simplifying healthcare access by meeting patients online and the importance of learning by doing to accelerate personal and business growth. The power of storytelling when engaging customers and investors, and of how to leverage video-based social media to reach both consumers and decision-makers effectively.
Donโt Forget
โโโ
Need help fundraising?
Start Here โ
โโโ
Interested in advertising with us?
Get in Touch โ
โโโ
Want to learn from more startup CEOs?
Check Out the Archive โ
โโโ
Forwarded this email?
Join for Free โ
โโโ
Who's Scott Nelson again?
See His Bio โ
Transcript
0:00:01 [upbeat music] It's like borrowing as much as we can from other categories that where we know consumers are bought in. So having that cross-category...
0:00:10 So I think even, uh, you know, from the ingredients we chose specifically.
0:00:13 So you know, uh, resveratrol [chuckles] from totally skincare, which you've used for forever, and you know it's, comes from red wine, and it means antioxidants. Like, it works the same in your nose.
0:00:23 You know microbiome from Poppi. [chuckles] Mm-hmm. You know what, and all, you know, like, well, guess what? It works the same in your, in, in your nose.
0:00:29 So trying to take those analogies and draw them across in those same stories, I think that, in my background, has really paved the way for a much easier conversation instead of having to educate from scratch.
0:00:38 [upbeat music] Hey everyone.
0:00:47 In this episode of SNL, we sat down with Lorne Lacre, the founder and CEO of Wizard Wellness, which is commercializing a drug-free, three-step allergy care system designed to rebalance the nasal microbiome.
0:00:57 For the past 20-plus years, Lorne has worked in advertising at Procter & Gamble, global marketing at L'Orรฉal, product development at Estรฉe Lauder, and as an innovation advisor to Unilever Prestige.
0:01:07 At Luxury Brand Partners, he helped launch O&Co, IGK, and One/Size by Patrick Starr. He also served as chief innovation and R&D officer at Voyant Beauty and is an Ulta Beauty Accelerator mentor.
0:01:17 Here are a few topics we explored in this conversation. First, how do you build trust in a new category when customers aren't sure the science is real?
0:01:24 Second, what does it take to win over customers in a category they usually ignore? Third, when should you involve large retail partners, and what can they bring to the table?
0:01:32 And last, best practices for earning buy-in from technical teams. Before we dive into today's episode, a quick word about our sponsor, Metal.
0:01:39 If you're heading toward your next fundraising round, finding the right investors, getting warm introductions, and managing the process alongside everything else can take up a ton of time. That's where Metal comes in.
0:01:48 It's an AI-native operating system built for CEOs raising venture rounds.
0:01:52 You can use it to identify investors most likely to back your company, map connections in your network who can make introductions, organize your data room, and keep existing investors in the loop with AI-powered updates.
0:02:03 Metal is used by thousands of founders and CEOs across 40-plus countries who have successfully used the platform to close over 100 rounds in 2026 alone.
0:02:11 You can get 20% off Metal using the link in the show notes for this episode. All right, let's get into the interview. [upbeat music] Hi, Lorne. Welcome to the show. Appreciate you coming on.
0:02:25 Wow, thanks so much for having me. I appreciate it. Yeah, looking forward to, uh, learning a lot more about Wizard, um, as well as your background kind of before founding the company.
0:02:31 But, um, I recorded a very short bio at the outset of this episode. Let's start there.
0:02:34 Give us, like, the one-minute kind of overview, sort of elevator-style pitch on your, your journey leading up to founding the company and, and, and taking on the, the CEO role.
0:02:42 So I have been always kind of built my career around sitting in between marketing, R&D, and kind of commercialization, so always mostly actually in beauty and personal care.
0:02:53 So started my career out of business school at NYU and at L'Orรฉal, global marketing.
0:02:58 Moved to Clinique, part of Estรฉe Lauder, working product development, so technical storytelling, working closely with R&D and technical, uh, services.
0:03:05 And then joined a luxury brand incubator called Luxury Brand Partners. So that was where the guys, they started a company called Bumble Bumble Haircare- Huh.
0:03:13 And sold that to Estรฉe Lauder, and then decided they could start to create brands on their own. This was kind of early days when you saw the rise of kind of indie beauty brands emerging.
0:03:21 So joined them, created a brand called O&Co, which is a salon haircare brand.
0:03:26 And my role was really coming up with the product idea, working with the founders to put their finishing touches on it, and then work with contract manufacturers, uh, raw material suppliers, packaging, regulatory claims, et cetera, to kind of commercialize it.
0:03:39 So created O&Co, IGK haircare brand with Sephora, One/Size by Patrick Starrr color cosmetics line, and then, and some other brands.
0:03:46 And then went for five years as chief innovations officer at Voyant Beauty, which is the largest beauty and personal care contract manufacturer in North America, so partnering with companies like J&J, Unilever, Procter & Gamble, formulating and filling and innovating on the manufacturing side.
0:04:00 So heading up a team of 85 chemists, technicians, quality, et cetera, globally. And then, uh, my last role was at, uh, Unilever Prestige, advising their portfolio brands on innovation strategy.
0:04:11 So all the time I've been an allergy sufferer, which has gotten worse with age, and, uh, you know, I've seen beauty, wellness, kind of all this, all these categories really merge, um, and seeing all these categories get disrupted, like mood and gut and sleep, with non, I'd say non-OTC, non-prescription solutions, um, coming to the aisle, which has been exciting to see with- Mm.
0:04:33 ... you know, some interesting science, some more probably real than others- [chuckles]... and some more science-backed than others, but interesting form factors, science, et cetera, and becoming commercialized.
0:04:42 And I was traveling about three years ago and had forgotten my nasal spray when I was, uh, when I was going home to see family in Spain, and I always take an Afrin on the plane.
0:04:50 When I landed in Spain, I, like, ran to go get, like, uh, my Afrin. You know, trying to translate oxymetazoline to the, [chuckles] to the pharmacist in Spain.
0:04:57 And yeah, they, like, politely guided me to a non, you know, non-OTC, non-prescription solution, and, uh, it worked, and it had, like, all these skincare ingredients in it, like hyaluronic acid and botanicals and vitamin C and amino acids.
0:05:10 And I was like, "I never thought that you could use these ingredients in, in nasal care, actually." And I was like, "Is the mode of action the same? Does it do the same? How does it work?"
0:05:18 And that just started this kind of cur- cul- curiosity, and then it dawned on me that nobody's really touched allergy care, disrupted it like we've seen these other aisles.
0:05:25 There's no, like, Arm & Hammer or Gruns of allergy. So Wizard was that idea of, of kind of disrupting this aisle with the new science around nasal microbiome and new form factors, whether packaging or, or formulations.
0:05:38 Yeah. I like that framing. Gr- the, the Gruns of, of, of allergy. Yeah. I mean- Let's hope I have an outcome similar to his. [laughs] Not a bad target. Not a bad target at all. Correct. Yes, yes, yes. Yeah.
0:05:48 Uh, but this is, like, s- one of those categories that's like y- the exact question that you just framed up, right? Like, it's, uh, why not?
0:05:53 Like, why hasn't there been another brand that's, like, like, like, done something similar? Like, it's such a great question, and it feels like you're definitely onto something, right?
0:06:00 Because that was, [chuckles] that was one of my takeaways doing some research off of, off of this interview is, like, why- Like, why does it, why does it feel like Wizard's kind of, like, one of the first that's, like, that's doing something in this category, considering how big it is, right?
0:06:09 Correct. Especially this time of year, right? Recording this in, in October of [laughs] Yes, yes... of '26, for those listening after the fact.
0:06:15 It's, like, yeah, right in the, in, in the, in the throes of allergy season for a lot of, a lot of, a lot of folks. Yeah, so with that said, I, I'm looking at the website now, and you- it looks...
0:06:22 a- and your LinkedIn profile kind of simultaneously, but you officially started the company kind of a- about two years ago, roughly.
0:06:27 I mean, it sounds like you started kind of, kind of dabbling and kind of prototyping on some, some formulations even, even, even before that.
0:06:33 But have you kind of been at, at it or knee-deep in it, I guess, for, like, couple years now? I closed my pre- let's call it kind of pre-seed raise.
0:06:41 It was a little over, uh, like, a million and, and a half almost, uh, in October of '24, and that was really... Before that, it was kind of a, a deck and a dream. Mm.
0:06:49 So after that was kind of what kicked off actually being able to move forward with prototyping, and that was really first was around the research, so that was kind of the microbiome, proving out that was right, that was- Mm...
0:06:58 true, I guess. Mm-hmm. Uh, it worked. And then the formulation phase, and that was October of '24. So we launched D2C, call it February 1st of '26. Okay.
0:07:08 And then a year and change to get to market, and then Amazon, TikTok Shop, walmart.com in March of '26, and then we just rolled out across 4,000 retail doors- Wow...
0:07:18 Target, CVS, and Walmart over the course of August and early September of this year of '26, yeah. Yeah. Not, not wasting any time, I see. [laughs] No. No, no, no. [laughs] No, no.
0:07:28 That's, that's a, that's some broad, broad expansion. I, I definitely wanna double-click into that here over the, over the course of this, this conversation, right?
0:07:34 But for those that have never heard of the brand, right, Wizard Wellness, we'll link to it in the full write-up, but it's exactly as it, uh, the URL is exactly as it, as it sounds, right? Wizardwellness.com.
0:07:43 Gi- give me i- idea, right?
0:07:45 I mean, most people are gonna be listening to this, you know, versus kind of reading it, but, um, give us a s- a sense for kind of how your offering is differentiated versus kind of, like, you know, what, what someone would, would traditionally kind of, you know, take for, uh, for, for allergies that's, that's sort of non-prescription anyway.
0:07:58 Yeah. If you think about, uh, allergy care currently, there's kind of two parts to the aisle. One is OTC, so any, picture anything with, like, a drug facts box on it.
0:08:05 So that can be your Afrin or Flonase or Claritin or whatever it might be, but anything with a, kind of a active API that's regulated by the FDA. So with that comes a multitude of side effects, whatever it might be.
0:08:17 So whether it's rebound effect or, you know, limited usage, you know, about, beyond three days or drowsiness or whatever it might be. So kind of that's one bucket.
0:08:24 The second is this, I could say, this kind of smattering of natural homeopathic. So whether it's powered by, you know, herbs or botanicals or honey or whatever it might be, um, or kind of just, you know, straight saline.
0:08:36 While some more efficacious than others, as a consumer, you're kind of having to kind of hope that it's gonna work. There's not a lot of science behind it beyond just trust, I'd say.
0:08:44 So we picture Wizard as, as, as filling the white space in between of...
0:08:49 So we have, we leverage nasal microbiome science, so this is an emerging field within, within allergy care and mirrors what we've seen happen in skincare and gut care. Yeah. So same rules apply.
0:08:59 If you have a microbiome in dysbiosis, you, that weakens your gut barrier, weakens your skin barrier, and that can cause any, um, le- you know, leaky gut, eczema on the skin, acne, et cetera.
0:09:11 Same applies actually in the nose. So if you have a, a, a nasal microbiome and dysba- dysbiosis, it's shown actually that you're more apt to have allergic rhinitis. Mm.
0:09:18 So strengthening any, the nasal microbiome helps to strengthen your nasal barrier and reduce or eliminate symptoms. Um, so we leverage pre, post, and probiotics to do that.
0:09:28 So bringing in, I'd say, the scientific credibility, we have our own proprietary clinical behind that to, to prove that out.
0:09:34 So we bring in kind of, I'd say, the, the science backing of the OTC aisle, but then the clean, I'd say clean, natural formulation from the other side of the aisle.
0:09:42 So formulating only with synthetics that are proven safe and non-toxic but work, but kind of minimizing the ingredient list as we can and leveraging, I'd say, kind of active botanicals, similar, um, similar approach kind of from the, from the natural aisle.
0:09:56 So we kind of sit in the middle, yeah. Okay, got it. And I'm looking at your shop page right now, and it see, it feels like kind of a, a, a couple kind of core SKUs, right?
0:10:04 But all, all kind of centered around this idea of creating a healthy, a healthy microbiome within your nasal cavity then. Totally. Yeah. So everything is, um, everything is meant to be, like, a system usage.
0:10:14 So we know th- from consumer work that three out of four allergy sufferers, and y- as you mentioned, it's a, it's a huge TAM, so- Mm-hmm... actually, you know, almost one in three consumers have allergies. Mm.
0:10:24 Three out of four allergy sufferers are using three to five products to solve their allergy issues. Wow. So it's not one silver bullet, and that's across OTC prescription and non-OTC or non-prescription.
0:10:32 So we felt like we needed to offer kind of a suite of solutions. So we have nasal rinses, nasal sprays, inhaler sticks, and oral supplements, and have structured it much like actually a skincare line. Mm.
0:10:43 So kind of a three-step process, so cleanse, relieve, and balance, to help with educating and helping consumers navigate the line, but all leveraging our pre, pro, and postbiotics that all help to, uh, clinically prove and work together to, uh, rebalance the nasal microbiome.
0:10:57 Yeah. Okay. Okay. Got it. That's super, uh, su- super helpful. And you mentioned, uh, just a, just a few minutes ago, you're, you're expanding across, like, a, a myriad of different channels, right?
0:11:06 We're recording this in the early Q4 of '26, but you're in, you're obviously D2C online, right? But if I'm a consumer, I can most likely find this on TikTok Shop, use it... Where, where else? TikTok Shop.
0:11:17 Uh, we are in CVS, 1,400 CVS stores, 1,700 Walmart stores, and 1,000 Target stores, yeah. Got it. And Amazon, yeah. Yeah. Cool.
0:11:24 I love these stories where you're, you've got, like, a pretty, a pretty technical background, although it, it, like, it's, it's, it's sort of like y- you grew up in the world of, like, aesthetics and kind of more of that arena, but you're bringing, like, a very kind of scientific approach to a, a category, at least one side of the category here, that is, you know, comes with a little bit of, I don't know, a little, little bit of skepticism, right?
0:11:44 Mm. Like, does this stuff really work? Yes. And, you know, hasn't been studied, but y- obviously you're bringing a, you're bringing a fair amount of, uh, uh, scientific and technical rigor to it.
0:11:51 So, um, it's another area, right? That I wanna kind of explore in the next, uh, you know, call it thir- 30 or 40 minutes or so. But with that said, again, everyone listening, wizardwellness.com is the website.
0:12:00 We'll link to it in the full write-up. I definitely encourage you to check it out.
0:12:02 But, um, Lauren, if it's okay with you, I wanna take a step back and, um, kind of go back in time and learn a little, little bit more about how you, how you, how you got here. And you- Yeah...
0:12:10 you touched on, on, you know, kind of the, the 20-plus years, right? That you spent, you know, kind of leading up to, uh, to founding Wizard Wellness, and you mentioned kind of the p- the personal story.
0:12:18 But, you know, a lot of us that are more entrepreneurial in nature, right? We may, like, we may suffer from something, have an idea, and, like, think about it but never really start a company around it, right?
0:12:27 But you obviously were like- I'm, I'm going all in, right? I'm gonna spend the next, call it five to 10 years, you know, really, you know, going after this. So like, what, what was it?
0:12:35 Like, were there a few, like, obvious signals? 'Cause you also... I mean, you have a lot of entrepreneurial, like other startup experience.
0:12:39 You also sit on the, a number of different boards, you know, advise, consult, et cetera. But this is something that you're like, "Okay, I'm, I'm doing this," you know? But like, what, what was it?
0:12:47 [laughs] I, you know, I think it's like a... I never really thought about doing my own thing, and it was one of those... And I m- I think every...
0:12:53 I've talked, spoken to a few entrepreneurs, and I think there's like this moment where you have this realization. And for me it was like, so, well, one was the idea.
0:13:00 I think if K- and it truly was like an, a, that moment of, like curiosity. You know, I was in Spain, like I mentioned. There might, it might've been after a few glasses of wine. [laughs] But you know.
0:13:08 [laughs] But you know, like, like thinking and... And it was one of those things where I was like, "Wait, like nobody has done this?" Like, had to like do a double take and truly- Mm-hmm... like figure it out.
0:13:17 And then it was like, okay, then I was like, I had been doing work at Unilever around upstream, around precision microbiome and understanding- Mm...
0:13:24 like that world, because again, that's where I feel like my forte is around like taking that really, like I'd say like that kind of really upstream, maybe a bit more abstract R&D science and be able to translate it in a way that consumers can get excited- Mm-hmm...
0:13:36 about and really understand.
0:13:36 And to me, that precision microbiome is like the definition of working with the body, not against it, which is like the holy grail in terms of when it comes to things like sensitive skin, but also allergies, which you always feel like you have to trade off side effects, you know, experience with performance.
0:13:51 Once I r- realized, okay, maybe there's a science there, and the nasal microbiome actually was a valid emerging science in this field, and then you're seeing brands like Touchland, other brands get acquired, signaling, I'd say, consumer demand for- Mm-hmm...
0:14:02 these types of, uh, you know, these types of brands to, to disrupt these sleepy aisles. I was like, there's this like perfect storm of like, okay, if I don't do it, somebody else is gonna do it, for sure. Mm-hmm.
0:14:11 As we're seeing all these aisles get, you know, like over- Yeah... I say get exploited in the most loving way possible.
0:14:15 [laughs] But like, you know, it's like you, you, it's like it, it's only, it's only a matter of time before it's gonna happen.
0:14:20 If I can't do it, it's gonna be somebody else, and I have this amazing network around me of contract manufacturers and, and packaging and science and microbiome research partners and retail partners.
0:14:30 You know, I serve- Mm... as a advisor for Ulta's, for their accelerator program and like... So it's all these things. I was like, if I don't do it now, I'm gonna kick myself later, and that was kind- Mm...
0:14:38 of the impetus, you know? So. Yeah. Sound like it, sound like it checked a lot of boxes, uh, right? For sure. I mean, yeah. For sure. Yeah. Undoubtedly.
0:14:44 Um, when you think about e- even like the, the most kind of recent, like sort of bigger role, right? Even at, uh, it, was it Volta? Is that, is that right? Am I pronouncing that correctly?
0:14:53 Um, the team that you led at, is it, was it, um, what was the name of the company? It was at, uh, Voyant. I'm sorry. Voyant. Voyant Digital. Yeah. Right?
0:15:00 Um, I think you, you mentioned that you, you were leading like a team of like 75, 80 R&D engineers, and you were beginning to kinda like, like dabble in this new project, right? Maybe it wasn't even a, a real thing yet.
0:15:10 Were there like a couple things that you're like, "Okay, this is seemingly starting to have legs," and coming from that experience, like leading a hu- a, a pretty, pretty significant, you know, team of, of, of R&D engineers, you're like, "We're definitely gonna do this," w- right?
0:15:22 At, at Wizard. Or, "We're definitely not gonna do this," right?
0:15:24 Where, what were a cou- couple of the key things that you definitely wanted to kind of, you know, build into Wizard in the, in the early days as you kind of started to, started to really, um, peel back the layers of, of this, this problem that you were trying to solve?
0:15:34 I think because at, at Voyant, I was, role there was chief innovation officer, and that was tru- that was heading up almost all were R&D technicians, qual- al- almost all had... I don't share a educational [laughs]...
0:15:49 background of. So I think what that experience was was understanding how can you walk into a situation where you need to have the credibility to be able to get a buy-in and- Mm...
0:16:00 belief in what you're doing, even if you might not have check all the boxes of, you know, I'm not an ENT, nor am I an allergist.
0:16:06 However, I do have a curiosity, and I have a background to be able to build product, um, and to validate when a science is real or not, and can figure out how to commercialize and get it to market.
0:16:14 And so I think that that was one, a place where I honed that skills of figuring out how to actually surround myself with the right partners to be able to, to get to prove either X, Y, Z points, or to get that kind of, get the s- the, the scientific parts and pieces I needed to be successful.
0:16:28 And so that was be able to leverage into Wizard because, one, to be able to have the, to be able to pull the microbiome and the right research partners to be able to validate the science in a way that was actually scientifically sound and kind of would moat, help to moat our defensibility.
0:16:43 And then the second was the ability to kind of actually, you know, we own all our formulations, to be able to create those kind of from scratch as well as then to work with our proper now contract manufacturers to work with them to be able to scale those up in a way, you know, in under a year and a half was no small feat to do that seamlessly.
0:16:58 So I think that was a all... I'd have to say each of these experiences I feel like ladders up to Wizard, but that was definitely one that was helped from an operational and scientific side, uh, immensely, for sure.
0:17:08 When you're working with like a, a group of, of, of folks like that, right? Like pure, pure, pretty kind of sci- scientists, right? Yeah.
0:17:14 And, and may- maybe, maybe speak to this, um, you know, for other, let's say more, more commercial leaders, right?
0:17:19 That are in kind of the same boat where they've got this idea, they think it has legs, but it's, it's fairly technical nature, right? Yes.
0:17:26 And so they do need to surround themselves with other engineers, other scientists, et cetera.
0:17:30 Are there a couple, like, things that have worked really well for you in trying to, like, trying to coalesce a group like that where maybe you're, you know, you know, you don't have the same background, as you mentioned, right?
0:17:38 But you've been able to, it seems like you, you have a unique ability to kind of c- do that well. So any- anything that comes to mind, right? That, that's led to kind of success in that area?
0:17:45 The ability to, one, I mean, empathize and listen is, like, beyond. I mean, they, uh... I learned early on that the chemists are the magic makers. Like, you will not...
0:17:53 Like, that's gonna who- that's how you're gonna shine, whether, you know. So being able to help them- The last thing that they, they, they wanna help you to be successful, and many chemists I find are really...
0:18:04 It's speaking a different language, and finding out the language that's gonna r- work for them, whether it's really taking quant- like s- you're translating emotions into quant- into numbers or whatever it might be.
0:18:13 But finding that ri- l- right language that's gonna resonate with them, but also being able to listen to them and take it at a pace that, that can work with them. Hmm.
0:18:20 Um, I find, I find that it can, it can pay dividends. So... And it's, well, I, I know this sounds so silly, but, like, getting them excited and bought into the big picture. I find that chemists- Mm...
0:18:29 sometimes are often the last to know and don't really see, and are thought of, I think, as the lowest, some of the lowest on the l- on the totem pole.
0:18:35 And you find, and you elevate creative and branding and all these other pr- you know, the sexier parts and pieces.
0:18:40 And whereas I think the formulation can often become that real technical piece of it, is actually, in my part, what adds the longevity to the brand at the end of the day, or the- Hmm... the, the true difference.
0:18:49 Uh, so having them bought into the big idea and getting excited about what can be is... I think that that's, that's, that's all been paid off and, and paid dividends. Yeah. Yeah.
0:18:57 So kind of shine- shining a light on, on them, right? And sort of making them the heroes of the, of the story along the way. Correct. Correct. Correct. Uh, so I think that's, that's pretty important.
0:19:03 On, on that note, I wanna kind of, you know, get into a little bit more, um, some, some product related questions, right?
0:19:08 'Cause as you're developing this, you've gotta make it, you know, simple enough, right, for the, for the end user. Not, not only, um, use, right, like step one, step two, step three, but also understand, right?
0:19:17 'Cause you're tackling kind of a new, a new category, as you mentioned, right, which is the kind of the nasal, nasal microbiome.
0:19:21 So were there a couple, like, you know, key things that you sort of worked through as you were kind of designing the early SKUs, right, that, that allowed you to kind of accomplish the simplicity that is needed to not only tell, tell the story, but also use the, use the product as well?
0:19:34 Yeah, absolutely. So what we... Well, uh, one, it's, like, borrowing as much as we can from other categories that, where we know consumers are bought in. So having that cross-category...
0:19:43 So I think even, uh, you know, from the ingredients we chose specifically, so other... You know, you, you know
0:19:49 resveratrol [laughs] from Cotali skincare, which you've used for forever, and you know how it's, it's comes from red wine and it means antioxidants. Like, it's works the same in your nose. You know microbiome from Poppi.
0:19:59 [laughs] Mm-hmm. You know, and, and all... You know, like, well guess what? It works the same in your, in your nose. So trying to take those analogies and draw them across- Mm...
0:20:07 and those, and those same stories, I think that, in my background, has really paved the way for a much easier conversation instead of having to try and, uh, to educate from scratch.
0:20:14 And so trying to do that as much as we can with the... Not only building the formula, so as we put together the ingredient deck, uh, doing it that way, and then creating kind of this ritual, like, approach.
0:20:24 So it's kind of one, two, three steps of helping to create an education factor.
0:20:27 It's, you know, I m- I, I mentioned, like, that stat around, you know, we did a 600-person study before we launched and, you know, three out of four allergy sufferers using three to five products to solve their allergy issues.
0:20:38 That's a lot of products. Just like a skincare line that you don't... So you don't... Most people don't use just a cleanser as part of their skincare regimen.
0:20:46 They'll typically use a cleanser and a moisturizer, a cleansing serum or serum and moisturizer, et cetera.
0:20:49 And most skincare brands offer education in terms of how to navigate the line or how to use the line, and no allergy brands do that.
0:20:56 You're kind of left to figure it out in the aisle and put together a regimen that works for you. So we felt like if we could leverage that education factor to help to simplify and make the- Hmm...
0:21:06 the process even smoother, then that would be... That's an easy win. And I think the last piece of it was just, like, pulling on consumer insights around friction. So, like, taking a, like a...
0:21:15 I hate to say it, so cheesy, but, like, a Steve Jobs approach of, like, pulling friction out wherever you could. And allergies is so full of friction everywhere you look. Hmm.
0:21:22 Like, the product experience, like, you know, it's like, it burns. You can't use it for more than three... All these other things.
0:21:28 So kind of making it acceptable for daily use, making it taste good, that's, like, one thing. Like, another- Mm-hmm... sensorial piece of it.
0:21:34 Making the product, the design look like something you wanna have in your bag and you're not embarrassed about, you want, like you want on your shelfie.
0:21:39 Like, making the oral supplements, we didn't use pills that people... Some people hate pills 'cause it makes them, like, gag. Like, so we have it on a fast dissolve strip that tastes good.
0:21:46 So it's like alleviating friction wherever we can. Mm-hmm. Like, the nasal rinses are pre-mixed and preserved, that you don't have to use distilled, distilled water because that's annoying. [laughs] Annoying- Yeah...
0:21:53 and it makes me not wanna have to do it. So anywhere we can.
0:21:55 So, like, that kind of piece of it, removing that friction, I think was another place where we, you know, tried to design our way into something that people would want to adopt and use daily. Yeah. Yeah.
0:22:04 That, that is such a great question to always just k- keep coming back to, right? Is, is there more friction to be removed from this? Totally. Or how can I make this more simple?
0:22:11 And a lot of, a lot of the founders, CEOs that, that, that are on the program too come from a, uh, I would say, um, more of a traditional medical device background. So I think that, that question applies really anywhere.
0:22:20 Whether you're developing something in a kind of a relatively new category that's DTC or OTC or some implant, right, that goes in the body. If you can make your offering as simple as possible, that often leads to...
0:22:33 Like, that often will move the needle more in terms of adoption- Totally... versus something that, that is backed by the most robust science ever, right, in the, in the history of the world.
0:22:41 But if it's, if it's harder to use and kind of more complicated, it, it just, it just kind of falls on deaf ears eventually. [laughs] You know what I mean? You've lost, you've lost them already. Yeah.
0:22:48 I mean, that design- Yeah... is just as important as the, as the tech and the science. So, uh- Yeah... and I think a lot of people don't think about the balance of the two. Yeah. Mm-hmm. Yeah. Yeah.
0:22:57 The other thing that you, you mentioned out, out of the gate in, in terms of answering this question was, um, was kind of just looking at, at, at what others have done, right?
0:23:03 I'm such a big believer in kind of, I think it's Austin Kleon's quote of... Or his book, actually. Um, what is it? Good Artists Steal but Great Artists Copy or something. [laughs] No, no, no. Good Art...
0:23:11 Well, I think I have that reversed. I can't remember exactly. It's been a while since I- [laughs]... since I read that. I think that's the title of the book maybe, if I remember correctly. Anyway. Makes sense. It's...
0:23:17 But it is. Yeah. [laughs] It's like I'm such a big fan of that. Like, oftentimes what you're doing is not totally rocket science.
0:23:22 It's, it's been done somewhere in some other kind of capacity, and you just gotta kind of swipe certain aspects of it, right, and pull it into whatever you're, you're doing.
0:23:30 That's like, I love that, that sort of- Totally... sort of hack, hack or strategy, if you will, right?
0:23:34 It, it, it's so often can be done if you just look, if you take the time to kind of look elsewhere and see how other- Totally... others have done it in the past. Yeah. For sure. Totally. Yeah. Totally. Totally.
0:23:42 I want, I wanna talk a little bit about, like, kind of the messaging too, right? 'Cause this is also one when you're in, in your, in your house.
0:23:47 As you, as you begin to kind of gear up for this launch in early, early, uh, early '26, how did you go about kind of, like, translating this, right? Because I, I, I know...
0:23:56 Like, e- even though you make it sound so simple, but I know, I know it wasn't, right? To get to this i- i- idea [laughs] of, of helping people understand that nasal micro- na- nasal bi- microbiome is important, right?
0:24:06 I mean, that, that right now it sounds simple enough, but I'm sure it probably wasn't getting, getting to the stage.
0:24:11 So how did you kind of, like, how did you kind of narrow, narrow in on, like, the key, the key kind of messaging and, and positioning for the, for the brand?
0:24:18 You know, I, I go back to my, you know, my purview prior was, again, blue skies, blue sky within, you know, beauty and personal care.
0:24:27 And there you were seeing a lot of this precision microbiome emerge, as r- again, real science and real actives.
0:24:32 And I remember early days when I was, you know, discussing Wizard or presenting Wizard to investors, the number one question I got was exactly that, with like, "Well, is this real?" Like, every- [laughs]...
0:24:43 you know, micro- microbiome, they're like, "Oh, God, microbiome." And poor, you know, poor microbiome, like often c- you know, it's... I think it's been susceptible to, like, so much microbiome washing- [laughs]...
0:24:49 and does it, what does it do? And like, uh, you know, it's like the... thanks to things like Poppy and whatever, you know- Yeah... God bless, you know, they, it's a, it's a d- a dual site of storage or whatever. Mm-hmm.
0:24:57 But like, you know, anyway, but, but since then, I have to say that, like, the... you know, I liken it to, like, the amount... I don't know if you've been following, but like the, the in- influx of oral care brand- Mm...
0:25:06 disruptive oral care brands we've seen as of late, and it's all, they're all their stories are based around oral microbiome. [Instrumental music] Hey everyone, let's take a quick break.
0:25:15 Quick reminder that while we're cooking up something new from MedSider, all 250 plus interviews in our popular email-based courses are now officially consolidated over at scottnelsonlive.com.
0:25:25 These courses are completely free, self-paced, and delivered directly to your inbox over eight weeks.
0:25:30 You'll get actionable insights packed with winning formulas from world-class founders and CEOs, covering every key stage of the startup journey like fundraising, device design and development, clinical and regulatory strategy, commercialization, and M&A.
0:25:43 Each course covers hard-earned lessons shared by the medical device and health technology entrepreneurs who've joined our program. You can explore the courses at scottnelsonlive.com/courses.
0:25:53 Again, that's scottnelsonlive.com/courses. All right, let's jump back to the interview.
0:26:02 And I just read an article today about, from an early-stage investor, and she was mentioning that, like, every deck she's seen over the last, call it, six months has been all for oral care, right?
0:26:10 So every- there's a mad rush for oral care, and it's all around oral microbiome. And I think that that's, it's not if, it's when this is, the science is gonna catch up.
0:26:16 And I think that is, it's who's, who's gonna, to your point, who's gonna explain it the easiest in the, in the most succinct and in, in the, in the way that the consumer is gonna get it that's going to win.
0:26:25 And so for us, we again feel like this is a easiest analogy wins, and where we see this as like, it's just like a probiotic for your nose, and how we liken that to gut and skin, and continue to draw those analogies and get consumers to think about it.
0:26:38 So I remember when we did, um, some of the early-stage product market fit testing with consumers, and we had probiotic in the product concept.
0:26:46 And can I tell you, like, people lost their mind about having a product, like a nasal spray with probiotics in it, because th- they don't know what probiotics do, but they just knew that it meant good. Like- Uh.
0:26:55 [laughs]... you know, it looked good. And so like, that's, that, you know what? That's good enough for me. That's fine.
0:27:00 So then the education around rebalancing the ma- ma- the ma- nasal microbiome and all those things, that will come, but that's a journey that we have to take them on from an education standpoint. Mm.
0:27:08 And so I think we did a lot of compre- narrative compression around, like, what does that mean at shelf for the Wal- for a typical Walmart consumer, what does that mean?
0:27:14 And first is getting her or him to understand, okay, there's a steroid-free alternative or drug-free alternative that works. Second is, it's instant relief.
0:27:24 And then third is actually it preserves and strengthens the nasal microbiome.
0:27:28 And that third piece of it is what we're working on, you know, we continue to work on now to educate them and bring them along for the ride once they're involved with the brand and, and onboarded.
0:27:35 So it's taking all those ex- existing cues and then, uh, supplying them the education, both consumer testing and, and, uh, storytelling to get them to believe. Yeah. Yeah.
0:27:44 I mean, if you listen to this, I mean, you gotta, you gotta check out the science page on, on Wizard's site, wizardwellness.com, or just click on the science in, in the nav. It's just like a really good example.
0:27:53 I mean, if you're working on something that has, like, a pretty significant kind of patient-consumer overlap, they've just done a really good job, not only with the, the, the visuals, right, but, uh, but the copy alone, right?
0:28:02 Like, I'm just reading, like, uh, the paragraph on nasal bi- microbiome, you know. Just like the gut or skin, your nose ha- has its own microbiome, a community of microbes, et cetera, et cetera.
0:28:09 You probably read that paragraph a number of times. [laughs] I, I imagine. Re- re- written and rewritten the whole yesterday. [laughs] Oh, yeah, yeah, yeah.
0:28:15 Yeah, I mean, like, the Wizard 101 stuff, it's just really, it's just really, really well done. It's just a, a good example. Like, even though, um, you know, you may be working on a completely different category, right?
0:28:23 It's just, uh, these are the types of examples to kind of pull from in- Yes... in, in my opinion. Yeah. So it's, it's really good stuff. I think you, you also ran a, um, I think about a month-long IRB study too.
0:28:33 Uh, tell us a little bit kinda y- your approach to that, 'cause that, one, is unique, I think, for a consumer-first brand to, like, you know, actually allocate the resources necessary to, like, study this and validate it.
0:28:43 And then, and then two, like, how did you... Like, what, what, what sort of endpoints did you, did you, did you look for?
0:28:47 I mean, 'cause I- I'm sure there's probably a number of different, different things that you could have studied, but you narrowed in on a, on a, on a few. So maybe touch on, on that, that aspect of the, of the company.
0:28:55 I mean, to me, like, coming from beauty and personal care, like, you can't launch a product without clinicals.
0:29:01 Like, clinicals, consumer testing, the whole thing, and it was the, that was the biggest shocker to me is when I looked at the allergy aisle, there... Nobody...
0:29:08 Now, there's one product that just launched with us actually that had clinical testing, which is the wildest thing. So there's no natural homeopathic products that have any consumer clinical testing behind them.
0:29:19 Again, it's just as a consumer, you're expected to just believe, hope that, you know, honey, God bless it- [laughs]... is gonna work for you, you know, for whatever.
0:29:26 Which honey, don't get me wrong, uh, you know, is a very powerful ingredient, but- Mm. And then OTC, you just trust that that little white drug facts box is gonna work for you, right? Yeah.
0:29:34 So, like, and there's nothing in between. And so we said, listen, every product is gonna be consumer tested and is clinical.
0:29:39 So the clinical we went, we, we landed on was one that developed in partnership with my microbiome research partner, which I knew from actually my Unilever days and others, which has done large scale testing for, you know, top haircare, skincare brands, and now getting into, into wellness brands as well.
0:29:55 But what we designed, wanted to show, was this idea of, like, the correlation factor between the strengthening of mi- of the nasal microbiome and, and, and pro- and quality of life.
0:30:03 And what we sh- and what we proved out was- When you do feed the nasal microbiome and the right pre, post, and probiotics via nasal delivery and gut delivery, by the way, so modulating via those two which our patent is on and protects- Mm...
0:30:18 you shift the nasal microbiome in those with dysbiosis in 28 days. And what that links to is improved quality of life, which can signal many things.
0:30:27 One is, like, you know, whether it's I wanna be around my family and friends more, uh, I'm sleeping better, I can exercise more, my appearance, I look more refreshed, I have less dark- Mm-hmm... under-eye circles.
0:30:38 Like, the list goes on and on, how it, how allergies actually truly affect all these facets of your quality of life, so overall quality of life emerge and allergy symptoms reduce, or in some- Mm... cases are eliminated.
0:30:48 And those interestingly enough in our study were where we saw the, the most needle-moving was on those with the worst, with the worst allergies pres- Mm...
0:30:56 you know, where they had, you know, if yous think about your sad to happy face scale [laughs] when you go to the doctor. Yeah. Like, those with, like, the, the most sad faces, they were- Yeah...
0:31:04 the ones who self, self-admittedly said they had the worst allergy symptoms, those were the ones who in, uh, said that they saw the most improvement in their symptoms that we provided, which was amazing to see.
0:31:12 So- Huh...
0:31:13 we were excited to have this clinical because it truly did show that, like, again, it doesn't happen overnight, but microbiome is pretty tough to change, but we were able to do it with this, again, this blend of, of ingredients, yeah.
0:31:23 It's cool to see that, like, I mean, obviously for those that are listening that are, are, they, they kinda grew up in a, in a more kinda biotech, med tech background, this, this point is obvious.
0:31:31 But it's, it's cool to see, like, the brands that, the more consumer-facing brands are, are taking this more serious, right? Like, the need to actually, you know, to, to clinically validate th- their offerings.
0:31:41 And I think, I think consumers/patients, they're, they're, they're catching up to this, right?
0:31:44 Like, if you don't have, if you don't have decent data to support some of the, some of the, the messaging, the marketing claims that you're trying to make, it's oftentimes, you know, it's kind of a flash in the pan sort of story, right?
0:31:54 You're not gonna- Totally... you know, the longevity of your, of your, your c- your, your brand is just not gonna, not gonna be sustainable.
0:31:58 And it helps to story tell actually, though, adoption too, 'cause the whole goal of Wizard, it's not... You know, a lot of allergy care right now is, is reactive. Like, you wake up- Mm...
0:32:06 and oh, God, like, your eyes are puffy or whatever, and you go to, like, buy, I don't know, Afrin or Flonase or- Mm... hopefully you buy Wizard now. But, you know- [laughs]...
0:32:12 so but you're not really thinking ahead 'cause all allergy care sucks. So you're like- Yeah... I don't wanna, like, I don't wanna, I, like, as long as I can put it off purchasing and using, I want to.
0:32:20 The goal with Wizard is that you actually like to use it, and if you think about the nose as the air filter for the body, so hopefully you wanna, like, cleanse it just like you cleanse your body, your face, your hair daily hopefully or- Mm-hmm...
0:32:28 you know. Uh, so by doing so you improve your overall natural health.
0:32:32 And so we wanted to show, though, like, listen, by adopting this into natural routine, a lot of natural is challenging because you don't see results a lot of times immediately, like a Tylenol effect, right, which we as Americans become very used to, right?
0:32:45 You take a pill and you see something within 30 minutes, right, an effect. Mm. Mm.
0:32:48 So if you look at our, actually our science page, we do have a, a, the way we walk through all the, the results of the studies, actually we took some inspiration from, like, IM8 and some other supplement brands of saying- Mm...
0:32:58 listen, by day three, here's what you see. By day seven, here's what you see. By day 14. Like, so stay with us and here's what you'll see when.
0:33:05 Like, but keep using it 'cause that's the real magic is, like, the more you use it, the more you'll see. It's not gonna happen, like, much of it won't happen overnight.
0:33:13 You'll see some immediate relief, but really the magic comes at day, you know, day 14, day 28, when that, the s- results start to really build.
0:33:19 Yeah, so that's, so setting, setting the, the expectations, right- Totally... out of, out of the gate is sort of super helpful.
0:33:24 'Cause you're, you're answering kinda one of the questions I wanted to get to a- a- as well is which is e- educating, coaching, messaging to a, a segment of the population that, that does largely, you know, consume allergy-related products reactively, right- Yes...
0:33:34 as you, as you mentioned. So this is more, much more of a proactive kind of, you know, treatment if you will.
0:33:38 So beyond, beyond sort of, like, setting the expectations, right, i- anything else that comes to mind in terms of, like, helping you, like, see positive results and kinda changing this behavior?
0:33:48 So the 28-day clinical we mapped out, so we take, have them, like, along for a journey in our email. Actually our- Mm... email subscription flow is set up to do that as well.
0:33:56 So it, we follow up at each of those time points depending on the product that you bought to say, "Hey, by the way, today you should be feeling X, Y, Z," you know. Mm.
0:34:03 Like, check in, da, da, da, just to kind of, like, s- kind of nudge them along ju- but just to show that they should be starting to see that progression as well.
0:34:08 And then we also did with every product we did consumer testing as well.
0:34:12 So we did at minimum, uh, like our oral strips, we have a 25-person panel study, but, uh, most have a 50 or 100-person panel study where we've done those time points, like, immediate- Okay...
0:34:21 three-day, seven-day, and we put that actually on our product. Uh, we call it proof in the potion, but- [laughs]... we do kind of that, that, uh, that claims journey.
0:34:28 So, you know, x percent saw immediate congestion relief. By day three, x percent were breathing better. By day seven, x percent had, like, less puffiness in their face, whatever it might be.
0:34:35 But, but by product we show kind of what happens when you stick with it- Okay... based on other consumers.
0:34:41 And I found from, if you look at the data in beauty, most actually consumers relate and believe more in that type of data would, 'cause they're looking at ratings and reviews.
0:34:50 They believe in those percentages more than these kind of a more abstract clinical numbers- Mm... that might not, are harder to relate to. They wanna understand how it works for other people like them, yeah.
0:34:59 Oh, interesting. Yeah. That makes a ton of sense though, right? Yeah. 'Cause people naturally are gonna, are gonna, like, scroll to the bottom o- of the page to see reviews, right? Yes.
0:35:07 Um, or, or even just thinking about basic kinda search behavior, right? Like, I want the reviews, like, of- Totally... such and such product, such and such brand, et cetera. So that makes a- Totally...
0:35:15 that makes a ton of sense, right, for that. Why they gravitate, right, towards that sort of data versus, like, this yet led to x percentage increase and such and such score or whatever, right? Totally.
0:35:23 That's, like, totally kind of hard to understand and- Yes... hard to make sense of. Yeah, that's a, that's a really, really good point.
0:35:29 Let's chat a little bit about, you know, kind of like broader commercialization too because, like, this, the, the, the rapid expansion I kinda joked around before, but it's, like, it's, it's actually really impressive.
0:35:37 I mean, most, most [laughs] most brands at this, at this age don't get to launching through this many channels and es- es- especially, like, retail this, this quickly.
0:35:45 So I'm sure you're able to tap into a lot of your, your, your network, you know, to get here.
0:35:50 But, like, what other sort of, like, operational levers have you been able to pull, right, to, to get this right where, like, you're effectively in a huge amount of retail and online channels, right, in gosh, less than a, less than a year now since launching?
0:36:01 I would say this to any founder or anybody thinking about, you know, for me- My past has been, I'm like... I always describe myself as, like, a Sephora, Ulta guy. Like, that's been my, my bread and butter.
0:36:11 And, like, the magic there with building, truly building brands with them is as early as, we call it getting in the kitchen. Like, as early as you can bring them in the kitchen with the, with you, like- Hmm...
0:36:21 the better, right? So, like, it's not to have them define the brand by any stretch of the imagination, but it's...
0:36:25 They know their consumer better than anybody, and the m- the knowledge sharing is insane if you can get them in and get... And having them feel comfortable with the brand, that you're receptive as well to the feedback.
0:36:35 So I'm not one of those founders that's, like, so protective and so precious about this brand. I'm like, "I wanna grow this thing quickly," as you can tell. [laughs] As you can tell, and I...
0:36:44 Because I think it's so exciting, right? Hmm. And so I feel this, like... I feel this, this urgency. And so as soon as I could talk to those retailers, even at the exploratory, I was on it, honestly. Hmm.
0:36:53 So the minute I got a, a green light from Walmart, I was like, had my bags packed and was, like, flying to Bentonville.
0:36:58 And similar to Target, I was pushing the brokers as quickly as I could get them, even if it was just, like, again, for just early feedback, et cetera, before anything had been signed, before we had a line review, anything like that, you know, honestly.
0:37:07 So I think that was actually, a lot of the magic was, like, one, just having them getting eyes on the brand and getting their feedback on packaging or science or whatever it might be. And then two, I think that they...
0:37:18 What they do appreciate about Wizard is it is, is what you've kinda called out, is, like, the investment in science- Hmm... and to truly make it a standalone brand. So we're not copying other brands.
0:37:31 Like, it's not another, God bless, like, another protein chip brand. [laughs] You know, whatever it may be. God, there's, there's a place for everything, but, you know, anyway. [laughs] But there... It's truly...
0:37:38 It's, it's, it's legit science that we've validated with scien- legit science that we've validated with studies, et cetera. Yeah.
0:37:44 That, that, you know, it's, it's a standalone brand, and I think they were all excited for that. And so for us, those conversations were some of the easiest, to be hon- to be honest. Hmm.
0:37:51 Beyond just actually the capital, you know, onto my side of signing over half my [laughs] company away anyway to raise money. But anyway. Yeah.
0:37:56 But, and the operational challenges of getting all the inventory in and et cetera. But I think... And those conversations continue to be really dynamic.
0:38:03 It's not about you have to meet X velocity today or you're out tomorrow. It's like we... Let's grow together, uh, because this allergy aisle is, is early days of disruption, and, like...
0:38:14 And we're excited about what you're bringing. So it's been- Yeah... really awesome. It's more, you know, I'm more hard on myself than anything, so [laughs] that's more of the struggle. So anyway. Well, I, I, I, I...
0:38:23 That, that's unique. I o- I actually wasn't, wasn't, wasn't expecting you to say that because I gotta think that most, most people in your shoes, right, kinda nov- novel sort of category, right?
0:38:32 Not, not category, seriously, nov- novel sort of way, way to approach this, like, legacy category. They would've maybe had a tendency to kinda keep, keep things closer to the vest, right?
0:38:40 Like, I'm just gonna kinda build and self for a while and not really kind of, you know, invite people into my tent, so to speak, and- Sure...
0:38:46 you took, you took the opposite approach and said, "No, actually, let's begin to have relationships and conversations and discussions with, like, quite honestly, the, the biggest, the biggest retailers in the world- Yes...
0:38:55 as early as possible." And it sounded like that, that worked out quite well, right? Where, you know, you got to a point where you're ready to actually launch. It's like, okay, you know, g- game on.
0:39:03 Remember that, remember that thing that we discussed- [laughs]... three, three to four months ago? It's here now. Yes. Right? It's available. Yeah. [laughs] But it's hard...
0:39:08 But I think that's, but that goes to sh- I mean, I, you know, if you think, you know, we talked about career-wise of, like...
0:39:13 When I think about, when I think about how challenger brands and disruptor brands, I often think key, a key unlock for that is the ability to... The lower barriers to entry around manufacturing and go to market.
0:39:25 And if you think about beauty- Hmm... that's, that's now played out. It's like you can launch a beauty brand very easily 'cause contra manufacturing is easy, packaging is easy. All those things are easy to navigate.
0:39:34 Oral care, for example, I think five years ago when Boka launched or what- any of these other kind of disruptive oral care brands launched, it was really hard to find a contra manufacturer that made toothpaste or that made some of these, like, mouthwash or whatever it might be.
0:39:45 Now those are much more accessible, and that's why you're seeing, I think, a, a broader swath of oral care disruptive brands. Hmm.
0:39:53 When I tell you that putting together a supply chain for an allergy brand, [laughs] for an allergy brand was one of the most challenging things I've ever done, as somebody who puts together supply chains- Hmm...
0:40:02 you know, in my previous life for a living- [laughs]... it was so ch- I mean, finding the right s- somebody who filled the packaging. The packaging alone, like, coming up with the...
0:40:09 And, you know, we have two design patents on our packaging because of- Hmm... the two, and some medical device as well. Yeah. Like, so the ingredients, doing the tox testing, doing all the research, the...
0:40:19 All the, all of it was obv- Putting this all together in a year and a half was, like, crazy. But that's also, I think, a huge barrier to entry for a new brand. Hmm. So I don't think it's easily replicatable. I hope not.
0:40:28 Let's see. [laughs] But, uh, you know, I do think it's not if, it's when, but that's why I think it's a bit of a, it's a, it's a unique category from, from that perspective.
0:40:35 And, you know, Zyrtec just launched their first drug-free alternative, and we're unsurprisingly being merchandised together on shelf- Hmm...
0:40:42 in these retailers as this kind of, I think, new science-backed, drug-free category. Yeah. So I anticipate more players coming, more strategics, I know they are coming.
0:40:50 But if we can be first to market, and that's part of the reason why, you know, we're in the retailers we are, because I feel like I wanna own- Yeah... you know, that, that place in the aisle. Yeah.
0:40:58 In the era of AI, it seem, like... The, the, that natural question, I guess, to, to a, an, a newer, a newer kind of therapy, treatment, et cetera, is, like, what's the moat, in essence, right?
0:41:06 And I think old school thinking is, like, IP, right? Like, IP is the moat, et cetera. But a l- a lot of times in this, when it's so easy to build new things, right, software being one, [laughs] one, one example. Yeah.
0:41:17 But, like, the, the moat is being first to market and moving quickly and getting the shelf space and building the relationships with these, these retailers. Yes.
0:41:24 Because it's like there's not, there's not endless room for copycats. You, you- No... know what I mean? No. Agreed.
0:41:28 And so if you can, if you can kinda be a first, first to market and, and create the, sort of create the therapeutic kinda category, if you will. I think, I think... What, what, how do you describe this?
0:41:36 Non-scientific, scientifically validated- [laughs]... non-drug, uh, treatments, you know? I mean, that's- Yes. Yes... that's a good, that's a good- Yes. I like that. I like that a lot. Yeah.
0:41:44 And there's definitely a lot of consumer patient kinda tailwinds for that, for sure.
0:41:47 I know we don't have a ton of time, uh, left, Lauren, but let's talk a little bit about your, kinda your capital, uh, raising strategy, 'cause you've, you've raised, you know, fund- or kind of, um, money from across kind of beauty and more, I would say, typical kinda, kinda healthcare funds.
0:41:59 And so give us a sense for kinda your, your approach and maybe what's either maybe a couple things that worked well, a couple things that didn't work well.
0:42:05 Or, or maybe, maybe said a different way, if you had to kinda start from scratch, you know, is there anything that you, you would do the same or do differently?
0:42:11 Yeah, I mean, I probably did this all wrong, so [laughs] So I probably have a lot of lessons. [laughs] So I... Yes, we've raised...
0:42:18 So the, the brand has raised, like, close to 7 million to date, so enabling all the inventory, like, you know- Mm... entry into retail and all the testing, et cetera.
0:42:25 So we have an amazing cap table, as you mentioned, so spanning beauty, so True Beauty Ventures, G9 Ventures, into more health, so, like, Able Partners, which is in, like, Grunes and- Mm...
0:42:34 um, into Oura Ring, some of the others. Pave Health, Venture Collective, which was in Wunder Belly, which got acquired by P&G. So a lot, a lot of great partners and which, uh, which have come to- together via networks.
0:42:45 So, you know, I think it's... If I had to do it all over again, and this is probably s- such a stupid... Everybody probably knows this, so I was may- [laughs]... probably the last to know. But- [laughs]...
0:42:54 you know, ti- the importance of timing your fundraising to your milestones- Mm... was, like, the thing that nobody ever told me about, so you know, or that I never got. So, like, you know- Mm...
0:43:02 I- I feel like every time I needed capital it was like I was, like, a month or two out from getting a written commitment for retail, or it was a month or two... You know- Mm...
0:43:10 always kind of right before these milestones where, which would have, I think, validated the, the valuation or whatever it might have been. Luckily, I have amazing, again, amazing investment partners, which- Mm...
0:43:19 you know, again, they kept, uh, they, you know, they all kept coming in and et cetera. But I think that was the big, my, one of my bigger mistakes.
0:43:24 And then really not thinking about a lot of capital needs extensively enough to kind of minimize some of those raises. So, you know- Mm...
0:43:31 I parsed out a, a few, probably there's a couple different tranches, and so I probably would have hopefully condensed that a bit. So I don't think it's ever a perfect science, to be quite honest. No.
0:43:39 From what I hear- [laughs]... you know, but if, if I had to do it over again, I would have thought it more than, like, kind of mapping out those milestones, et cetera.
0:43:45 But I think, you know, having done it all over again, I think it's, like, probably worked out the way, way possible, so yeah. I, I think some of those, those points that, uh, they're only really...
0:43:53 You can only really, um, really truly understand them if you... u- until you do it, right? I mean, you could, like, read all kind... I mean- [laughs]...
0:43:59 read all kinds of blog posts, books, et cetera, on venture capital and think, "Okay, I've got this perfect approach."
0:44:04 And then until you actually get in the, get in the trenches and start doing it, it's like, yeah, maybe I could have, like, raised a little bit more at that point or timed the m- Yeah.
0:44:11 I mean, it's just, like, one, it's hard to do [laughs] when you're- Yes, yes... when, when you're operating a company.
0:44:15 And then two, it's just like y- um, stuff makes sense on paper and then you get into, like, the real kind of race, if you will, and it, you know, you don't have control over a lot of things, right? Totally.
0:44:24 There's so many different dynamics at play. But yeah. 100%, yes. [laughs] So it's been a journey, like I said. There's...
0:44:28 And, you know, and the other thing too is I think is, like, which goes probably unsaid, but I never realized if you're a new entrepreneur having not entrepreneur, not working, not having worked with investors, not all money is the same, I'd say.
0:44:40 Like- Mm. And thank God I haven't learned this the bad way. All, all, I've, I love all my investors, I have to say, and I'm not just saying this 'cause I'm being recorded. Mm.
0:44:48 [laughs] I, [laughs] I do try to actually legitimately love them. Like, and I've seen actually how all of them add value in, in each unique ways. But- Mm... understanding that is, like, is amazing actually. Mm-hmm.
0:44:59 They believe in the brand, and they each, like, support it and lean in, and I think that's the one thing. Like, if I could educate, like, you to, like, think about that, like, it's got to...
0:45:07 It's a two-way street, and, like, really how are they, how are you gonna also leverage them? 'Cause it is truly a marriage. Yeah. And you are, you know.
0:45:13 So and they can be immensely helpful or, you know, quiet and maybe not so helpful, but hopefully the hope is they will be helpful and lean in and, and can be, you know, whether introducing you to future investors or operational support or just, like, sanity checks or whatever.
0:45:28 You know, like, one of my investors connected me with Walmart and CVS. Like, that would have never happened without that connection, which was, you know, it would be completely different, which is amazing.
0:45:35 So it's like all those different things can, can really add up, yeah. Yeah, yeah, no doubt. I, I 1,000% agree that, like, not, not all money is the same. I mean, 100%.
0:45:44 I mean, like, and oftentimes you may even want to prioritize or, or take maybe l- less on the valuation side if you can get the right- Totally... investors involved.
0:45:53 I mean, that's hun- that's totally worth it in the long game. And, and I didn't... That's something that I didn't realize four or five years ago.
0:45:59 I mean, not to, and not to say that I was, like, optimizing for, like, all things valuation, but just didn't realize the importance of that, right? Totally.
0:46:05 And how, how much, how much it really, it could really sway things one, one, one, you know, e- either in the positive or, or the, or the negative, you know, however- And at your, to, and to your point, and, and specific to the value, uh, specific to the stage that you're at as well- Mm-hmm...
0:46:17 of those, 'cause I out the gate was, I think, going too big and not at the s- the s- the sweet... Having those that are used to the sweet spot where you're at, not only...
0:46:25 'cause they understand what you're going through. Yeah. Like, [laughs] they're not solely looking at, you know, some of the number or whatever and understanding this could be, things are gonna be different.
0:46:32 So it's, um, yeah, it's a, it's a dance for sure, but yeah, agreed, yeah. Yeah, yeah. I know we've got a couple minutes left here. I wanna get to the rapid fire portion of the interview.
0:46:38 But again, wizardwellness.com is the website. We'll link to it in the full writeup. Highly encourage everyone to check it out.
0:46:43 Um, even if you're probably a third of you, at least a third of you that are listening to this have, have an allergy issue. [laughs] Yes. At the very least you could be a consumer of the, uh- [laughs]...
0:46:51 of, of, of, of the product. I'm certainly gonna check it out. It's like, gosh, my sneezing's at a all-time high right now. You know what I mean? Mm-hmm.
0:46:56 So, um, uh, I need to, I need to, I need to be thinking about things a little bit more proactively it sounds like based on, uh- Yes. [laughs]... based on this, this discussion.
0:47:02 [laughs] Um, so with that said, uh, a few rapid fire questions, uh, for you, Lauren. First, first one, um, take us out to the end of, end of 2027.
0:47:10 Is there, like, one major milestone or kind of thing that you're really, really, really looking forward to over the next 12 months? Yeah. We have a sick innovation roadmap. So I think- Mm...
0:47:18 we've launched Core, which I, I already thought is innovative, but I think our '27 innovation truly brings the brand to life in, like, really rad breakthrough ways. Mm. So I'm really excited about that, yeah.
0:47:27 That's cool. What's the billboard message or, like, the one lesson that you think every, every entrepreneur should really, really understand? Oh, man. I'd say, uh, don't be hard on yourself. [laughs] Mm.
0:47:37 [laughs] So yeah. [laughs] That's my big lesson, yes. [laughs] Yeah. It's a good, it's a good reminder. It's a good reminder. Good reminder, yes.
0:47:44 Uh, especially if you're, if you're e- e- either, either, either both ways, right?
0:47:47 If you're having a, a ton of success for the time being or you're in a, in a, in a kind of a downward, downward, uh, kind of tranche right now, uh- And that can happen within 24 hours, by the way. No doubt.
0:47:56 That, that's [laughs] so yeah. No doubt. It's a good, it's a good, it's a good message, for sure. All right, last one.
0:48:01 Um, is there, is there a piece of advice, right, if we could rewind the clock and, you know, whisper in the, uh, the ears of the younger, uh, Lauren, you know, maybe 10, 15 years ago, what would you, what would you say to you?
0:48:12 What would you say to yourself? I know this sounds cheesy, but I think the universe always has a plan, and I think this is you doing everything you need to. Mm. So I think entrepreneur, like, I...
0:48:21 Truly this journey has pulled on every bit of experience- Mm... my network, everything I've ever done, so I think everything happens for a reason.
0:48:27 And, you know, I'm st- still learning everything new every day, but, uh, you know, wouldn't have done anything differently. Yeah. That's good stuff. All right, good way to wrap up the, the, the chat.
0:48:36 Thanks aga- thanks again for doing it, Lauren. This was fun to learn- Yeah... not only about yourself, but also about, uh, about the company. Thank you so much for having me.
0:48:41 I will, I will be watching, I will be watching for the Grunes style or the Grunes- Yes. [laughs]... the Grunes type of stratosphere exit. [laughs] I got you. There you go. No, but this, this has been fun.
0:48:51 I'll have you certainly on again. But thanks, uh, again for everyone listening who made it this far. Appreciate your attention as always. Until the next episode goes live, everyone take care. Hey, it's Scott again.
0:48:59 One quick thing before you go. You see, I love bringing you insightful conversations with the best founders and CEOs of medical device and health technology startups.
0:49:07 But here's the thing, I'd be super grateful if you could help me reach even more ambitious doers who share our passion.
0:49:13 So if you found value in this podcast, if you found yourself nodding your head while listening, or if you simply enjoy what we're doing, please take a moment to leave us a review. It's super easy.
0:49:21 Just open the Apple Podcasts app, Spotify, or the podcast app of your choice. Search for our show and scroll down to the ratings and review section.
0:49:28 Leave your honest thoughts and hit that five-star rating if you think we're worthy.
0:49:31 Your feedback is incredibly important, and it's the best way to ensure we keep bringing you awesome discussions with leading founders and CEOs. So take a moment to be a good friend and leave that review today.
0:49:40 All right, enough talk about reviews. Stay tuned for another informative episode coming at you soon.
0:49:44 [outro music]
